Bernstein Reaffirms Their Buy Rating on Cognex (CGNX)
π·οΈ Bernstein analyst Jay Huang reaffirmed a Buy rating on Cognex (CGNX) with a price target of $66.00.
π The company reported quarterly revenue of $252.34 million and net profit of $32.66 million for the quarter ending December 31, exceeding last year's figures.
π Corporate insider sentiment is negative due to increased insider selling over the past quarter, including a recent sale by Director Papadimitriou Angelos.
β Analyst Jay Huang holds a 4-star rating with an average return of 18.0% and a 70.49% success rate according to TipRanks.
π Competing analyst actions include a downgrade to Hold by PerPlexity and a Buy from Google Hardware Equipment and Parts.
π° Goldman Sachs raised Cognex's price target to $70, while Barclays increased it to $64.
β‘ JPMorgan upgraded Cognex from Underweight to Neutral in their recent assessment.
π DA Davidson raised their price target to $55, and TD Cowen set their target at $75.
π£οΈ The article includes syndicated content related to top stock recommendations and market analysis tools.
π‘ Advisory notes suggest letting winners run and avoiding sales based on insider activity.
- price target of $66.00 was set by Jay Huang from Bernstein who maintained a Buy rating.
- Revenue grew 17% year-over-year to $252.34 million in the quarter ending December 31, with net profit increasing 15% to $32.66 million.
- Goldman Sachs raised Cognex's price target to $70 from $68 indicating confidence in growth potential.
- Barclays increased their price target to $64 from $61 reflecting positive outlook.
- JPMorgan upgraded Cognex to Neutral from Underweight signaling improved sentiment.
- TD Cowen raised price target significantly to $75 from $50 demonstrating strong upside.
- Multiple analysts including Bernstein, Goldman Sachs, Barclays, and TD Cowen have recently increased or maintained bullish positions.
- Corporate insider sentiment is negative as evidenced by increased insider selling activity over the past quarter.
- Director Papadimitriou Angelos recently sold 4,150 shares worth $230,657 in February 2026, indicating potential lack of confidence from company leadership.
- TipRanks recorded a downgrade to 'Hold' from PerPlexity on April 7, despite other analyst buy ratings.
- Analyst coverage shows mixed signals with only some firms raising price targets while others downgraded or maintained lower valuations.